医学
肺炎
肺结核
重症监护医学
疾病
慢性阻塞性肺病
药品
哮喘
呼吸道疾病
普通感冒
免疫学
药理学
肺
内科学
病理
作者
Ayodeji Oluwabunmi Oriola,Adebola O. Oyedeji
出处
期刊:Molecules
[MDPI AG]
日期:2022-05-10
卷期号:27 (10): 3054-3054
被引量:7
标识
DOI:10.3390/molecules27103054
摘要
Never has the world been more challenged by respiratory diseases (RDs) than it has witnessed in the last few decades. This is evident in the plethora of acute and chronic respiratory conditions, ranging from asthma and chronic obstructive pulmonary disease (COPD) to multidrug-resistant tuberculosis, pneumonia, influenza, and more recently, the novel coronavirus (COVID-19) disease. Unfortunately, the emergence of drug-resistant strains of pathogens, drug toxicity and side effects are drawbacks to effective chemotherapeutic management of RDs; hence, our focus on natural sources because of their unique chemical diversities and novel therapeutic applications. This review provides a summary on some common RDs, their management strategies, and the prospect of plant-derived natural products in the search for new drugs against common respiratory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI